|
| | HB4146 Engrossed | - 2 - | LRB100 14115 SMS 28871 b |
|
|
1 | | (B) if the enrollee has entered the third trimester |
2 | | of pregnancy at the
time
of the physician's |
3 | | disaffiliation, that includes the
provision of |
4 | | post-partum care directly related to the delivery.
|
5 | | (2) Notwithstanding the provisions in item (1) of this |
6 | | subsection, such
care shall be
authorized by the health |
7 | | care plan during the transitional period only if
the
|
8 | | physician agrees:
|
9 | | (A) to continue to accept reimbursement from the |
10 | | health care plan
at the
rates applicable prior to the |
11 | | start of the transitional period;
|
12 | | (B) to adhere to the health care plan's quality |
13 | | assurance
requirements
and
to provide to the health |
14 | | care plan necessary medical information related
to
|
15 | | such care; and
|
16 | | (C) to otherwise adhere to the health care plan's |
17 | | policies and
procedures,
including but not limited to |
18 | | procedures regarding referrals and obtaining
|
19 | | preauthorizations for treatment.
|
20 | | (3) The health care plan shall not modify an enrollee's |
21 | | coverage of a drug during the plan year for any enrollee if |
22 | | the drug has been previously approved for coverage by the |
23 | | plan for a medical condition of the enrollee, the plan's |
24 | | prescribing provider continues to prescribe the drug for |
25 | | the medical condition, and the patient continues to be an |
26 | | enrollee of the health care plan. Prohibited modifications |
|
| | HB4146 Engrossed | - 3 - | LRB100 14115 SMS 28871 b |
|
|
1 | | referred to in this paragraph (3) include, but are not |
2 | | limited to: |
3 | | (A) increasing the out-of-pocket costs for a |
4 | | covered drug; |
5 | | (B) moving a prescription drug to a more |
6 | | restrictive tier; or |
7 | | (C) removing a prescription drug from a formulary. |
8 | | This paragraph (3) does not prohibit a health care |
9 | | plan, by contract, written policy or procedure, or any |
10 | | other agreement or course of conduct, from requiring a |
11 | | pharmacist to effect substitutions of prescription |
12 | | drugs consistent with Section 19.5 of the Pharmacy |
13 | | Practice Act, under which a pharmacist may substitute |
14 | | an interchangeable biologic for a prescribed biologic |
15 | | product, and Section 25 of the Pharmacy Practice Act, |
16 | | under which a pharmacist may select a generic drug |
17 | | determined to be therapeutically equivalent by the |
18 | | United States Food and Drug Administration and in |
19 | | accordance with the Illinois Food, Drug and Cosmetic |
20 | | Act. |
21 | | This paragraph (3) does not apply to a health plan |
22 | | as defined in the State Employees Group Insurance Act of 1971 |
23 | | or medical assistance under Article V of the Illinois Public |
24 | | Aid Code. |
25 | | (b) A health care plan shall provide for continuity of care |
26 | | for new
enrollees as follows:
|
|
| | HB4146 Engrossed | - 4 - | LRB100 14115 SMS 28871 b |
|
|
1 | | (1) If a new enrollee whose physician is not a member |
2 | | of the health care
plan's provider network, but is within |
3 | | the health care plan's service
area,
enrolls in the health |
4 | | care plan, the health care plan shall permit
the enrollee
|
5 | | to continue an ongoing course of treatment with the |
6 | | enrollee's current
physician during a transitional period:
|
7 | | (A) of 90 days from the
effective
date of |
8 | | enrollment if
the enrollee has an ongoing course of |
9 | | treatment;
or
|
10 | | (B) if the enrollee has entered the third trimester |
11 | | of pregnancy at the
effective date of enrollment, that
|
12 | | includes the provision of post-partum care directly |
13 | | related to the delivery.
|
14 | | (2) If an enrollee elects to continue to receive care |
15 | | from such physician
pursuant to item (1) of this |
16 | | subsection, such care shall be authorized by the
health |
17 | | care plan for the transitional period only if the physician |
18 | | agrees:
|
19 | | (A) to accept reimbursement from the health care |
20 | | plan at rates
established
by the health care plan; such |
21 | | rates shall be
the level of reimbursement applicable to |
22 | | similar physicians within the health
care plan for such |
23 | | services;
|
24 | | (B) to adhere to the health care plan's quality |
25 | | assurance
requirements
and to provide to the health |
26 | | care plan necessary medical information
related to |
|
| | HB4146 Engrossed | - 5 - | LRB100 14115 SMS 28871 b |
|
|
1 | | such care; and
|
2 | | (C) to otherwise adhere to the health care plan's |
3 | | policies and
procedures
including, but not limited to |
4 | | procedures regarding referrals and obtaining
|
5 | | preauthorization for treatment.
|
6 | | (c) In no event shall this Section be construed to require |
7 | | a health care
plan
to
provide coverage for benefits not |
8 | | otherwise covered or to diminish or
impair preexisting |
9 | | condition limitations contained in the enrollee's
contract. In |
10 | | no event shall this Section be construed to prohibit the |
11 | | addition of prescription drugs to a health care plan's list of |
12 | | covered drugs during the coverage year.
|
13 | | (Source: P.A. 91-617, eff. 7-1-00.)
|
14 | | Section 99. Effective date. This Act takes effect upon |
15 | | becoming law.
|